These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1354908

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
    Weir MR.
    Postgrad Med; 2009 May; 121(3):90-8. PubMed ID: 19491545
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B.
    Blood Press; 2004 May; 13(3):137-41. PubMed ID: 15223721
    [Abstract] [Full Text] [Related]

  • 9. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J, Faülhaber HD.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():77-82. PubMed ID: 15700490
    [Abstract] [Full Text] [Related]

  • 10. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?
    Kountz DS.
    Postgrad Med; 2009 Jan 27; 121(1):14-24. PubMed ID: 19179810
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Beta-blockers in hypertension.
    Hansson L.
    J Hypertens Suppl; 1987 Aug 27; 5(3):S61-7. PubMed ID: 2889813
    [Abstract] [Full Text] [Related]

  • 15. [Beta-blockers and arterial hypertension. Evidence-based medicine or excessive perseverance?].
    Verdecchia P, Angeli F, Achilli P, Castellani C, Repaci S, Ambrosio G.
    G Ital Cardiol (Rome); 2007 Sep 27; 8(9):552-8. PubMed ID: 17972424
    [Abstract] [Full Text] [Related]

  • 16. Nebivolol: a third-generation beta-adrenergic blocker.
    Veverka A, Nuzum DS, Jolly JL.
    Ann Pharmacother; 2006 Sep 27; 40(7-8):1353-60. PubMed ID: 16822893
    [Abstract] [Full Text] [Related]

  • 17. [Current position of beta-adrenergic blockers in the management of arterial hypertension].
    Rumboldt Z.
    Lijec Vjesn; 2007 Sep 27; 129(6-7):237-40. PubMed ID: 18018716
    [Abstract] [Full Text] [Related]

  • 18. [Which beta receptor blockers should be used in hypertension?].
    Werning C.
    Fortschr Med; 1980 Feb 07; 98(5):157-60. PubMed ID: 6102958
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nitric oxide mechanisms of nebivolol.
    Maffei A, Lembo G.
    Ther Adv Cardiovasc Dis; 2009 Aug 07; 3(4):317-27. PubMed ID: 19443516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.